306 related articles for article (PubMed ID: 32985309)
1. Association of trimethylamine
Zhang P; Zou JZ; Chen J; Tan X; Xiang FF; Shen B; Hu JC; Wang JL; Wang YQ; Yu JB; Nie YX; Chen XH; Yu JW; Zhang Z; Lv WL; Xie YQ; Cao XS; Ding XQ
Ren Fail; 2020 Nov; 42(1):1004-1014. PubMed ID: 32985309
[TBL] [Abstract][Full Text] [Related]
2. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
Kaysen GA; Johansen KL; Chertow GM; Dalrymple LS; Kornak J; Grimes B; Dwyer T; Chassy AW; Fiehn O
J Ren Nutr; 2015 Jul; 25(4):351-6. PubMed ID: 25802017
[TBL] [Abstract][Full Text] [Related]
3. Trimethylamine-
Zheng Y; Tang Z; You L; Wu Y; Liu J; Xue J
Ren Fail; 2020 Nov; 42(1):580-586. PubMed ID: 32576072
[No Abstract] [Full Text] [Related]
4. Trimethylamine
Stubbs JR; Stedman MR; Liu S; Long J; Franchetti Y; West RE; Prokopienko AJ; Mahnken JD; Chertow GM; Nolin TD
Clin J Am Soc Nephrol; 2019 Feb; 14(2):261-267. PubMed ID: 30665924
[TBL] [Abstract][Full Text] [Related]
5. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
[TBL] [Abstract][Full Text] [Related]
6. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
7. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
[TBL] [Abstract][Full Text] [Related]
8. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
9. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease.
Senthong V; Wang Z; Fan Y; Wu Y; Hazen SL; Tang WH
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792653
[TBL] [Abstract][Full Text] [Related]
10. Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study.
Lever M; George PM; Slow S; Bellamy D; Young JM; Ho M; McEntyre CJ; Elmslie JL; Atkinson W; Molyneux SL; Troughton RW; Frampton CM; Richards AM; Chambers ST
PLoS One; 2014; 9(12):e114969. PubMed ID: 25493436
[TBL] [Abstract][Full Text] [Related]
11. Association of indoxyl sulfate with heart failure among patients on hemodialysis.
Cao XS; Chen J; Zou JZ; Zhong YH; Teng J; Ji J; Chen ZW; Liu ZH; Shen B; Nie YX; Lv WL; Xiang FF; Tan X; Ding XQ
Clin J Am Soc Nephrol; 2015 Jan; 10(1):111-9. PubMed ID: 25332316
[TBL] [Abstract][Full Text] [Related]
12. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
[TBL] [Abstract][Full Text] [Related]
13. Elevated Serum Trimethylamine N-Oxide Levels Are Associated with Mortality in Male Patients on Peritoneal Dialysis.
Fu D; Shen J; Li W; Wang Y; Zhong Z; Ye H; Huang N; Fan L; Yang X; Yu X; Zhou Y; Mao H
Blood Purif; 2021; 50(6):837-847. PubMed ID: 33596582
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
[TBL] [Abstract][Full Text] [Related]
16. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients.
Shafi T; Powe NR; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Hostetter TH
J Am Soc Nephrol; 2017 Jan; 28(1):321-331. PubMed ID: 27436853
[TBL] [Abstract][Full Text] [Related]
17. TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function.
Gruppen EG; Garcia E; Connelly MA; Jeyarajah EJ; Otvos JD; Bakker SJL; Dullaart RPF
Sci Rep; 2017 Oct; 7(1):13781. PubMed ID: 29061990
[TBL] [Abstract][Full Text] [Related]
18. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.
Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490
[TBL] [Abstract][Full Text] [Related]
19. Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis.
Wang M; Li XS; Wang Z; de Oliveira Otto MC; Lemaitre RN; Fretts A; Sotoodehnia N; Budoff M; Nemet I; DiDonato JA; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
Eur Heart J; 2023 May; 44(18):1608-1618. PubMed ID: 36883587
[TBL] [Abstract][Full Text] [Related]
20. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]